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Histologic features in patients with TMA and without TMA
HSCT patients with gastrointestinal symptoms (n[50)
TMA/
iGVDH
n¼15
No TMA/
iGVDH
n¼21
No TMA/
no iGVDH
n¼14
p¼value
Figure. Intestinal microangiopathy
Abstracts / Biol Blood Marrow Transplant 21 (2015) S206eS239 S219enzymes (which are highly polymorphic), all milk was
screened to ensure the presence of these oligosaccharides.
Results: Ten children were treated with milk, 8 boys and 2
girls. Ages at transplant ranged from 6 to 40 months. Di-
agnoses included non-malignant hematopoietic disorders
(n¼8) and leukemia (n¼2). Three children had sibling do-
nors, 1 a matched aunt and 6 unrelated donors; all received
bone marrow grafts. Treated cases were compared with 4
young children transplanted in the same time period who
received standard nutrition under the supervision of the
BMT dietician. Milk was given to provide 40% of caloric needs
(as breast milk cannot provide all nutritional needs for
children older than 6 months), from day -3 through day +14
after transplant. Enteral human milk was well tolerated with
all children receiving all the milk planned for administration.
Microbiome analysis showed no differences between study
groups at the start of transplant. Signiﬁcant differences were
observed between milk treated and control patient micro-
biomes at day 10 after transplant, when, consistent with
microbiome changes previously reported with GVHD risk
(Jenq et al 2012), control patients had signiﬁcantly increased
facultative anaerobes Streptococcaceae and Actino-
mycetaceae compared to milk fed patients. Measurement of
sIL2r levels showed elevation of levels at day 14 in controls
compared with cases.
Conclusions: This preliminary study suggests a possible role
for human milk in modulation of the microbiome and
reduction of a pro-inﬂammatory environment and a ran-
domized study is now in progress. Synthetic human milk
oligosaccharides have the potential to extend this strategy to
adults, and are currently being tested in a mouse model of
GVHD.Mucosal hemorrhages 12 (80%) 11 (52.4%) 5 (36%) 0.057
Loss of glands 11 (73.3%) 8 (38%) 0 (0%) <0.0001
Intravascularschistocytes 10 (66.7%) 5 (23.8%) 3 (21.4%) 0.016
Intravascular
ﬁbrinoid debris
8 (53.3%) 2 (9.55%) 2 (14%) 0.008
Intravascularmicrothrombi 4 (26.6%) 0 (0%) 0 (0%) 0.010
Endothelial cell swelling 13 (86.6%) 13 (61.9%) 7 (50%) 0.086
Endothelial cell separation 8 (53.3%) 3 (14.3%) 1 (7%) 0.007
Total denudation
of mucosa
7 (46.7%) 3 (14.3%) 0 (0%) 0.005293
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Introduction: We showed that high risk transplant-associ-
ated thrombotic microangiopathy (TMA) can present with
multisystem involvement and has poor outcome after HSCT
with <20% 1-year survival (Jodele, Blood 2014). TMA may
involve intestinal vasculature and can present with bleeding
and ischemic colitis. There are no established pathologic
criteria for diagnosis of intestinal TMA (iTMA). The goal of
our study was to review available tissue specimens obtained
after HSCT in order to identify histologic features of iTMA.
Methods: Fifty consecutive HSCT patients who underwent
endoscopy for gastrointestinal symptoms were evaluated for
histopathologic signs of iTMA using 8 histologic criteria
described in literature: mucosal hemorrhages, loss of glands,
schistocytes, ﬁbrinoid debris in the vessel lumen, intravas-
cular microthrombi, endothelial cell swelling, endothelial
cell separation and total denudation of mucosa (Figure). The
reviewing pathologist was blinded to patients’ clinical
history. Histologic markers were listed as present or absent.
For patients having multiple evaluations after HSCT, the
ﬁrst diagnostic tissue sample was used for this study.
Patients were divided into 3 clinical groups based on the
presence or absence of systemic TMA and intestinal graft
versus host disease (iGVHD): TMA/iGVHD, no TMA/iGVHD,and noTMA/no iGVHD. Systemic TMA was diagnosed using
rigorous clinical and diagnostic criteria. Comparison among
the groups was done using Fisher exact test.
Results: Fifteen patients (30%) had a clinical diagnosis of
systemic TMA.Out of 35patientswithout TMA, 21had clinical
and histologic evidence of gut GVHD while 14 did not. Inci-
dence of stage 3-4 gut GVHD was similar in the TMA/iGVHd
andnoTMA/iGVHDgroups (79%vs 64%). All histologic signs of
iTMA except for mucosal hemorrhages and endothelial cell
swelling were signiﬁcantly more common in patients with
systemic TMA (p<0.05). Intravascular thrombi were exclu-
sively seen only in patients with systemic TMA (Table).
Conclusions: We identiﬁed histologic features of iTMA that
can be used to delineate vascular injury of the bowel in pa-
tients with TMA after HSCT. Recognition of these histological
signs in patients with gastrointestinal symptoms after HSCT
may guide clinical decisions.
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